CompletedNot Applicable

The Risk of Falls Index for Patients With Neuromuscular Disorders

Germany30 participantsStarted 2023-09-01

Plain-language summary

The combination of short quantitatively assessing muscular function and balance in combination with short clinical scores, can be a new valid approach to evaluate the patient risk of fall and help to create a quick checkup test to prescribe an appropriate assistive device. The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with neuromuscular diseases (NMD) based on correlation between clinical assessments between two groups of NMD patients and scales used to assess risk of falling for patients.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients between 18- and 65-year-old * Patients with adequate cognitive and communication function to fill out the scales assessing risk of falling * The neuromuscular disease needs to be confirmed by genetic report and/or disease deepening neurophysiological examination. Exclusion Criteria: \- Patients which are not able to perform motoric functional assessments without assistive gait device.

What they're measuring

FBIndex

Timeframe: 2 years

Trial details

NCT IDNCT05890833

SponsorLMU Klinikum

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-09

View on ClinicalTrials.gov More Inclusion Body Myositis trials